High Expression of MTA1 Predicts Unfavorable Survival in Patients With Oral Squamous Cell Carcinoma

In Vivo. 2021 Jul-Aug;35(4):2363-2368. doi: 10.21873/invivo.12513.

Abstract

Background/aim: Metastasis-associated protein 1 (MTA1) plays a role in ATP-dependent nucleosome disruption activity and histone deacetylase activity and may indicate DNA methylation activity. MTA1 may also be involved in the progression of oral squamous cell carcinoma (OSCC).

Patients and methods: MTA1 immunoreactivity was analyzed using immunohistochemical (IHC) staining analysis in specimens from 281 OSCC patients. Kaplan-Meier analysis was used to determine the prognostic value of MTA1 for overall survival.

Results: High MTA1 expression was significantly associated with female gender and lymph node metastasis. Multivariate analyses showed the independent prognostic role of high MTA1 expression in patients with OSCC of poorer mean survival.

Conclusion: MTA1 expression, detected by IHC staining, could be an independent prognostic marker for patients of OSCC.

Keywords: MTA1; Metastasis-associated protein 1; oral squamous cell carcinoma; overall survival.; prognosis.

MeSH terms

  • Biomarkers, Tumor / genetics
  • Carcinoma, Squamous Cell* / genetics
  • Female
  • Head and Neck Neoplasms*
  • Histone Deacetylases / genetics
  • Humans
  • Mouth Neoplasms* / genetics
  • Prognosis
  • Repressor Proteins / genetics
  • Squamous Cell Carcinoma of Head and Neck
  • Trans-Activators

Substances

  • Biomarkers, Tumor
  • MTA1 protein, human
  • Repressor Proteins
  • Trans-Activators
  • Histone Deacetylases